Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 50
Summary
- Conditions
- Nasal Obstruction
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 22 years and 125 years
- Gender
- Both males and females
Description
This is a prospective, non-randomized, multi-center follow-up study to collect long term quality of life (QOL) data on a cohort of patients who participated in the Aerin Medical TP258 study "A Prospective, Multi-Center, Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the...
This is a prospective, non-randomized, multi-center follow-up study to collect long term quality of life (QOL) data on a cohort of patients who participated in the Aerin Medical TP258 study "A Prospective, Multi-Center, Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the Aerin Medical Device". The TP258 study followed subjects out to 26 weeks post-procedure. This QOL study will collect data at 12, 18, 24, 36, 48 and 60 months post-procedure.
Tracking Information
- NCT #
- NCT03290300
- Collaborators
- Not Provided
- Investigators
- Study Director: Scott Wolf, MD Aerin Medical Principal Investigator: Ofer Jacobowitz, MD, PhD ENT and Allergy Associates, Middletown, NY
Get Well Soon